Assertio Holdings | DEPO - Operating Expenses

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $105.8M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
ANI Pharmaceuticals USD 217.93M 287.88M Dec/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Cara Therapeutics USD 5.94M 983K Sep/2025
Daiichi Sankyo JPY 468.57B 15.34B Dec/2025
Ironwood Pharmaceuticals USD 57.33M 8.63M Dec/2024
J&J USD 17.44B 1.53B Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Omeros USD 59.16M 20.13M Jun/2024
Pfizer USD 12.91B 79.89B Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025